Program Details

General Details

Tuesday, May 18, 2021



Virtual Program – Participants will receive program link upon registration. 






Should patients with NASH fibrosis undergo bariatric surgery as primary treatment?

PRO: Tufts Medical Center

CON: The Warren Alpert Medical School of Brown University


Should early transplant (<6 months) be considered in patients with known alcoholic hepatitis with cirrhosis?

PRO: Beth Israel Deaconess Medical Center

CON: Lahey Hospital & Medical Center


Is liver biopsy essential in the diagnostic algorithm for biliary atresia?  

PRO: Boston Children’s Hospital

CON: Hasbro Children’s Hospital



  1. Beth Israel Deaconess Medical Center (BIDMC)
  2. Boston Children’s Hospital
  3. Hasbro Children’s Hospital
  4. Lahey Hospital & Medical Center
  5. The Warren Alpert Medical School of Brown University
  6. Tufts Medical Center


Event Moderators

Caroline Jouhourian, MD

Dr. Caroline Jouhourian grew up in Massachusetts and attended undergraduate school at University of Michigan, Ann Arbor, and subsequently completed medical school at Drexel University College of Medicine in Philadelphia. She made her way back to Massachusetts for her internal medicine residency and gastroenterology fellowship at Tufts Medical Center in Boston. She first became involved with the American Liver Foundation when she ran the marathon on their behalf in 2017 to honor her patients. She has since enjoyed partaking in patient outreach, the patient runner connection, and more recently, supporting subsequent runners! She has also ran the New York City half marathon on behalf of the American Liver Foundation. She currently works at the Integrated GI Consultants of Greater Lower in North Chelmsford, and takes pride in educating and providing care to her liver patients and families.

Daniel Pratt, MD

Daniel Pratt, MD received his B.A. from Bowdoin College and his M.D. from the Johns Hopkins University School of Medicine.  He completed a residency in Internal Medicine and a fellowship in Gastroenterology and Hepatology at the Tufts-New England Medical Center. He served on the faculty of the Tufts University School of Medicine from 1995 until 2004.

Dr. Pratt was the Medical Director of the Liver Transplant Program and Clinical Chief of the Division of Gastroenterology at the Tufts Medical Center. He joined the faculty of the Harvard Medical School and the MGH Gastrointestinal Unit in 2004.

Dr. Pratt’s particular area of clinical interest is autoimmune and cholestatic liver disease including autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, and IgG4 associated liver disease. He also does work in cholangiocarcinoma, hepatocellular carcinoma, viral hepatitis, and cirrhosis/endstage liver disease. Dr. Pratt is the head of the PSC Registry at MGH.

Dr. Pratt has written extensively on liver disease and has been the recipient of numerous teaching awards.


Emily Bethea, MD

Dr. Emily D. Bethea is the Associate Clinical Director of Liver Transplantation at Massachusetts General Hospital. She received a B.S. from the University of Wisconsin and an M.D. from the University of Chicago Pritzker School of Medicine. She completed Internal Medicine residency training at Brigham and Women’s Hospital where she stayed on for an additional invited year as a chief medical resident. She completed Gastroenterology and Hepatology fellowship followed by an Advanced Transplant Hepatology fellowship at Massachusetts General Hospital. She remains active in numerous societies and organizations, including the MGH Institute for Technology Assessment where she continues to apply simulation modeling and decision analytic methods to answer clinical questions and improve resource optimization in the areas of viral hepatitis, non-alcoholic fatty liver disease, and organ transplantation. She remains dedicated to the clinical care of patients with liver disease.

Alan Epstein, MD

Dr. Alan Epstein is a practicing Gastroenterologist in Providence, RI. Dr. Epstein graduated from Boston University School of Medicine in 1985 and has been in practice for 34 years. He completed a residency at Beth Israel Medical Center. Dr. Epstein also specializes in Internal Medicine. He currently practices at Roger Williams Medical Center and is affiliated with Roger Williams Medical Center. Dr. Epstein accepts multiple insurance plans including Aetna, Tufts Health Plan, and Harvard Pilgrim. Dr. Epstein is board certified in Internal Medicine. Dr. Epstein also practices at Dermatology Associates Inc in Providence, RI.


Dr. Thomas Sepe is a clinical professor of medicine at the Alpert Medical School of Brown University, Director of the Liver Center at University Gastroenterology and Director of Clinical Trials in Hepatology. He is board certified in gastroenterology and is affiliated with Rhode Island Hospital, The Miriam Hospital and Roger Williams Medical Center. He completed medical school at Mount Sinai School of Medicine and his residency was completed at Beth Israel Hospital and Harvard University. His areas of interests are in Cirrhosis, Hepatitis B, Hepatitis C, and Steatohepatitis.

Uzma Shah, MD

Dr. Uzma Shah is a pediatric gastroenterologist and hepatologist who currently serves as the Clinical Chief for the Pediatric Gastroenterology, Hepatology and Nutrition Division at Massachusetts General Hospital (MGH).  She is also the Medical Director of the Pediatric Liver Transplant Program and the Director of the Pediatric Hepatobiliary and Pancreas Center also at MGH.

Dr. Shah previously served as the Director of Research at Harvard Medical School Dubai and the Chief of Pediatric GI at the Aga Khan University Hospital. This work led to involvement in leadership committees nationally and internationally for the development of clinical and academic, Pediatric Hepatology, Transplant Hepatology and Pancreatic medicine. Additionally, this includes work on several steering committees for AASLD and NASPGHAN in policy as well as in training. Dr. Shah has served for seven years as the Hepatology expert for the Sub Board for Pediatric Gastroenterology at the American Board of Pediatrics.

Dr. Shah cares for a large clinical cohort of pediatric patients with nonalcoholic fatty liver disease (NAFLD) at MGH, and is involved in research efforts investigating NAFLD, PSC as well as pancreatic disease.  One key research initiative that they are currently developing has been in the study of microRNAs in obese and lean pediatric NAFLD.  Dr. Shah serve as a site PI for The Pediatric Consortium for the Study of PSC and am involved in the International Autoimmune Hepatitis Group as well as with Graft Injury Survival Group.  She also serves as Site PI for INSPPIRE, a multi-center consortium for the study and investigation of pancreatic disease in children.  In this role, Dr. Shah plays an integral part in the two NIH funded research projects (INSSPIRE 1 and 2) as well as in the development of clinical guidelines for the evaluation and management of pediatric pancreatic disease. Dr. Shah is also involved with the Herscot Center for Tuberous Sclerosis as well as for the HHT, Hereditary Hemorrhagic Telangiectasia group at MGH. Dr. Shah is additionally involved in CFLD and therapeutics related to that. Dr. Shah’s previous research included work with Hepatitis A and Entecavir in the treatment of Chronic Hepatitis B.

Beth Israel Deaconess Medical Center


Maria Andreea Catana

Maria-Andreea Catana, MD

Dr. Catana is a transplant hepatologist with clinical and research interests in hepatocellular carcinoma.  She is the Co-director of the Liver Tumor Program at Beth Israel Deaconess Medical center and a member of American Liver Foundation New England since 2019. ​


Hirsh Trivedi

Hirsh Trivedi, MD

Hirsh Trivedi is currently a third year gastroenterology & hepatology chief fellow and T32 research fellow at Beth Israel Deaconess Medical Center. He will be the Transplant Hepatology fellow at BIDMC starting in July 2021, and aims to have a career in clinical research related to liver disease. During his time off, Hirsh enjoys running in the summers and snowboarding in the winters. He looks forward to participating in ALF’s academic debates series.


Lauren Yang

Lauren Yang, MD

Lauren Yang is a Transplant Hepatology fellow at Beth Israel Deaconess Medical center.  Clinical interests include autoimmune liver diseases, portal hypertension, and liver transplant.  She enjoys teaching the medical student GI & liver course and studying the use of asynchronous learning tools in graduate medical education.  Her hobbies include anything outdoors and reading.

Boston Children's Hospital


 Scott Elisofon, MD

Scott Elisofon, MD

Scott Elisofon, MD serves as the Medical Director of the Liver Transplant Program. His specialties include childhood liver and biliary tract disease in addition to liver transplantation. Dr. Elisofon is board certified in Pediatric Gastroenterology and Pediatric Transplant Hepatology.

Dr. Elisofon is an active participant in SPLIT (Studies of Pediatric Liver Transplantation), a multi-center registry for Pediatric Liver Transplant. He has been a past committee member of the UNOS Pediatric Transplant Committee.

Locally, Dr. Elisofon serves on the Medical Advisory Council for the American Liver Foundation​


Anne Lyon, MD

Anne Lyon, MD is currently a first year fellow at Boston Children’s Hospital. She grew up in Brooklyn, NY and attended Stanford University for undergrad. She then completed a post bac at Bryn Mawr, medical school at Weill Cornell and Pediatrics residency at UCSF. She stayed on as a chief resident at UCSF before joining the GI/Hepatology fellowship at BCH. She has a strong interest in Hepatology as well as medical education.


Katherine Sweeny, MD

Katherine Sweeny, MD grew up in West Windsor, New Jersey. She was first introduced to gastroenterology by her father, a community gastroenterologist and hepatologist. After majoring in psychology at Bates College, she attended The Ohio State College of Medicine and decided to specialize in pediatrics. After admitting an infant with missed biliary atresia on her first day of GI service in residency at Cincinnati Children’s Hospital Medical Center, she decided to focus on GI and Hepatology for fellowship training. Currently, Kat is finishing up her Transplant Hepatology Fellowship at Boston Children’s Hospital and will stay on as junior faculty starting in July. Her academic focus is on fatty liver disease and improving the care of children with cirrhosis via quality improvement initiatives.

Hasbro Children's Hospital


Vania Kasper, MD

Vania Kasper, MD is the newest member of the New England Division Medial Advisory Council (MAC).  Dr. Kasper, is Director of the Liver Diseases Center and Medical Director of the CHANGES Adolescent Weight Management Program in the Division of Pediatric Gastroenterology, Nutrition and Liver Diseases at Hasbro Children’s Hospital.  Dr. Kasper is an Assistant Professor of Pediatrics and Clinician Educator at The Warren Alpert Medical School of Brown University. She is certified in pediatric gastroenterology and nutrition.

Dr. Kasper is involved in the annual Liver Life Walk Rhode Island with her team Hasbro Hepatic Heroes. She is hoping to expand her amazing team this year with new patients and families.


Meghan Gibson, MD

Meghan Gibson, MD is a third year Pedi GI fellow at Brown/Hasbro Children’s hospital. She is originally from Massachusetts and graduated from Boston College. She completed medical school at the University of Massachusetts and her pediatrics residency at Brown. Dr. Gibson is grateful for the opportunity to work with hepatologist Dr. Kasper during her fellowship and to take care of children with chronic liver disease, including families of children diagnosed with biliary atresia. In her spare time, she enjoys hiking and running, watching cheesy comedies and any shows made by Shona Rhimes, karaoke, and spending time with friends and family.


Aldo Recinos-Soto, MD

Dr. Aldo Recinos-Soto graduated from Universidad Francisco Marroquin (Guatemala City, Guatemala) in 2012, where he obtained his MD degree. He then completed his pediatrics residency in 2018 at Lincoln Medical Center in New York City, NY. He is currently a 3rd year fellow at Brown University / Hasbro Children’s Hospital. Upon completion of his fellowship, he will join Our Lady Of The Lake Children’s Hospital in Baton Rouge, Louisiana.

Dr. Recinos-Soto is fluent in Spanish and has an interest in neurogastroenterology and motility disorders in children. In his free time, he enjoy watching soccer, and investing.

Lahey Hospital & Medical Center


Fredric Gordon, MD, FAASLD, FAST, AGAF

Fredric D. Gordon, MD is a board-certified Gastroenterologist and Transplant Hepatologist, Vice Chair of Transplantation and Hepatobiliary Diseases, and Director of Hepatology at the Lahey Hospital & Medical Center in Burlington, Massachusetts. In addition, he is an Associate Professor of Medicine at Tufts Medical School in Boston, Massachusetts.

Dr. Gordon received his undergraduate degree from Boston University and his medical degree from the Boston University School of Medicine. He completed his postgraduate training in Medicine at the New England Deaconess Hospital in Boston, where he was later chosen Chief Resident. He performed his Gastroenterology fellowship at Deaconess Hospital in Boston and his fellowship in Transplant Hepatology at the Mayo Clinic in Rochester, Minnesota.

Dr. Gordon has published over 150 articles, abstracts and reviews regarding liver transplantation and tertiary treatment of hepatic disease.  He serves on the editorial board of the International Journal of Hepatology and as a reviewer for a number of prestigious journals including JAMA, the New England Journal of Medicine, Liver Transplantation, Transplantation, and the American Journal of Gastroenterology.  He has been the chair of the MELD Exceptions/Enhancements Subcommittee while on the OPTN/UNOS Liver & Intestine Committee and has been a member of the AASLD Practice Guidelines Committee.  He is the chair of the Individual Fundraising Committee and an at-large Board of Trustees member of the American Association for the Study of Liver Diseases Foundation. He was elected to the Board of Governors at Lahey Hospital and Medical Center. His areas of research interest include liver transplantation, living donor adult liver transplantation, Hepatitis C, portal hypertension, and the Transjugular Intrahepatic Portosystemic Shunt (TIPS). In addition to his active clinical practice and academic appointments, Dr. Gordon is a frequently invited lecturer and presenter both nationally and internationally. He is a fellow of the American Association for the Study of Liver Disease, the American Society of Transplantation, and the American Gastroenterological Association, and a member of the International Liver Transplantation Society among others.


Ahmed Abdelfattah, MD

Ahmed Abdelfattah, MD is a graduate of the University of Alexandria, Egypt. He moved to the Boston area in 2014 to conduct research at Massachusetts General Hospital’s Gastroenterology department.  Shortly thereafter, he sought further medical training in internal medicine at the Lahey Clinic.  After successful completion of his residency, he was selected as a Gastroenterology and Hepatology fellow at the Lahey Clinic. He is graduating GI fellowship in June of 2021, with plans to complete an Advanced Endoscopy Fellowship at the University of Massachusetts.


Jennifer Coukos, MD

Jennifer Coukos, MD graduated from the University of Rochester and then spent several years working in GI clinical research at Boston Medical Center. She completed medical school and residency training at University of Massachusetts Medical School.  After successful completion of her residency, she was selected as a Gastroenterology and Hepatology fellow at Lahey Clinic.  She is currently a second year GI fellow.

The Warren Alpert Medical School of Brown University


Eric. B. Newton, MD

Dr. Eric B. Newton is a clinical associate professor of medicine at the Alpert Medical School of Brown University. He is board certified in gastroenterology and is affiliated with Rhode Island Hospital, The Miriam Hospital and Roger Williams Medical Center. He completed medical school at University of Vermont and completed his residency at Brown University. His areas of clinical interest are in end-stage liver disease/cirrhosis, hepatitis B & C, fatty liver disease, hepatology, GERD, colorectal cancer and inflammatory bowel disease (IBD).


Waihong Chung, MD, PhD

Dr. Waihong Chung completed medical school at Warren Alpert Medical School of Brown University and his residency at the Icahn School of Medicine at Mount Sinai. His clinical and research interests include Alcoholic liver disease, NAFLD, management of diabetes in patients with chronic liver diseases and endoscopic management of upper and lower GI bleeding. His social interests include watching Marvel movies.


Jason Pan, MD

Dr. Jason Pan completed medical school at the Icahn School of Medicine at Mount Sinai and completed his residency and chief residency at Scripps Clinic and Scripps Green Hospital. His clinical and research interests are in hepatitis C and non-alcojolic fatty liver disease. His social interests include cooking, photography and travel.

Tufts Medical Center


Raza Malik

Raza Malik, MD

Raza Malik is an internationally recognized expert in the area of Liver Diseases. He is the Director of Hepatology and Associate Chief, Division of Gastroenterology at Tufts Medical Center. He has developed a multidisciplinary Liver Disease program that provides excellent clinical care for patients. A distinguished clinician and productive translational researcher, Dr. Malik has made important research findings in the field of non-invasive diagnosis of liver fibrosis & cirrhosis, Hepatitis B & C, NASH, Liver Failure and Liver Cancer. Between Oct 2009 and Apr 2019, he served as Staff Physician & Attending in Hepatology and Transplant Hepatology for Harvard Medical Faculty Physicians. In this role as Medical Director of the Hepatology & Hepatobiliary Program at Beth Israel Deaconess Medical Center, Harvard Medical School, he set up and developed the nationally recognized multidisciplinary programs in Liver Failure and Liver Cancer. Prior to this he was a Staff Physician in Hepatology on the Faculty of Medicine at the Royal Free & University College Hospital, University College London.

Training: Dr. Malik completed his MD at Kings College London and PhD in Liver Cell Biology and Hepatology at University College London. He completed training in internal medicine, intensive care medicine and general gastroenterology in the UK (Kings College Hospital, Royal Free Hospital, Imperial College Healthcare, Royal London Hospital and Cambridge University Hospital). He completed advanced training in hepatology and transplantation medicine at the Roger Williams Liver Unit at Kings College Hospital, the Sheila Sherlock Liver Unit at the Royal Free Hospital and at the Beth Israel Deaconess Medical Center, Harvard Medical School.


David Lee, MD

Dr. David Uihwan Lee is an advanced hepatology fellow and tufts CTSI-NIH research scholar currently serving his clinical and research terms at Tufts Medical Center – his primary interest is in prognostic and systemic cross-sectional outcome-based studies, in which he founded the Tufts outcomes-based research cohort to conduct various liver prognostic and cross-sectional evaluations. From his primary work, he has written and published over 80 abstracts and manuscripts, and has been featured as symposium speaker for the major GI conferences, including AASLD, ACG, and DDW. Furthermore, he is also the recipient of AASLD Early Career Investigator Award in Clinical/Translational Science Award and distinguished poster award (in both AASLD and DDW) for his primary research in the effects of malnutrition on liver outcomes of patients admitted with alcoholic hepatitis/cirrhosis, as well as other national cross-sectional studies. As prior speaker for the ALF advanced liver disease series, he is also excited to participate in this 2021 American Liver Foundation Academic Debate as a participant and co-fellow with other hepatologists and fellows.


Tara Orekondy, MD

Dr. Nayantara Orekondy is a first year Gastroenterology/Hepatology clinical fellow at Tufts University Medical Center.  She completed her Internal Medicine residency training at Rush University Medical Center and also completed a clinical Hepatology Fellowship at Loyola University Medical Center as a bridge between residency and fellowship.  While a clinical Hepatology fellow, Dr. Orekondy has worked in a high volume Transplant and General Hepatology clinic while also pursuing clinical research interests.   Her research focus involved evaluating the Stanford Integrated Psychosocial Assessment Tool (SIPAT) scores as predictors for alcoholic relapse in patients with alcoholic liver disease.  She has presented abstracts at multiple national meetings including the ACG and AASLD annual meetings as a medicine resident and hepatology fellow.  Additionally she has published review articles on management of Hepatitis C during pregnancy, and misconceptions surrounding the management of Hepatocellular Carcinoma.  During fellowship Dr. Orekondy’s goal is to further develop research interests in the areas of alcoholic and non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.